An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...
GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...
With a growing number of patients reaching hospitals at an advanced stage, doctors stress that timely urological screening is ...
EDMONTON, AB, April 20, 2026 /CNW/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a peer-reviewed ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...